FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma.

FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma.

FOXP3 is a forkhead transcription factor family member, implicated in T-cell regulation, activation and differentiation. FOXP3 has been shown to be a master control gene for the development and function of CD4+/CD25+ regulatory T-cells (T(reg)). In this study, FOXP3 protein expression has been analy...

Bibliografski detalji
Glavni autori:	Roncador, G, Garcia, J, Maestre, L, Lucas, E, Menarguez, J, Ohshima, K, Nakamura, S, Banham, A, Piris, M
Format:	Journal article
Jezik:	English
Izdano:	2005

Slični predmeti

FOXP3 expression in B and T cell lymphomas.
od: Roncador, G, i dr.
Izdano: (2005)

Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome.
od: Barrans, S, i dr.
Izdano: (2004)

Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation.
od: Haralambieva, E, i dr.
Izdano: (2006)

The significance of FOXP1 in diffuse large B-cell lymphoma
od: Gascoyne, D, i dr.
Izdano: (2016)

Is FOXP3 expressed in cutaneous T-cell lymphomas?
od: Banham, A, i dr.
Izdano: (2008)

The FOXP3 transcription factor as a regulatory T-cell marker
od: Banham, A
Izdano: (2008)

High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.
od: Carreras, J, i dr.
Izdano: (2006)

Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells.
od: Alvaro, T, i dr.
Izdano: (2005)

Expression of FOXP2 is up-regulated in lymphoid malignancies
od: Campbell, A, i dr.
Izdano: (2009)

Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sezary syndrome from other cutaneous T-cell lymphomas.
od: Klemke, C, i dr.
Izdano: (2006)

FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures
od: Wong, K, i dr.
Izdano: (2016)

The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma.
od: Brown, P, i dr.
Izdano: (2005)

Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level.
od: Roncador, G, i dr.
Izdano: (2005)

Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype
od: Santiago Montes-Moreno, i dr.
Izdano: (2010-08-01)

PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases.
od: Esperanza Martín-Sánchez, i dr.
Izdano: (2014-01-01)

The architectural pattern of FOXP3(+) T cells is an independent predictor of survival in patients with follicular lymphoma (FL)
od: Farinha, P, i dr.
Izdano: (2006)

The architectural pattern of FOXP3*T cells is an independent predictor of survival in patients with follicular lymphoma (FL)
od: Farinha, P, i dr.
Izdano: (2006)

Identification of FOXP1 Transcriptional Targets in Diffuse Large B Cell Lymphoma
od: Camilleri, E, i dr.
Izdano: (2012)

FOXP1 abnormalities in lymphoma: translocation breakpoint mapping reveals insights into deregulated transcriptional control.
od: Goatly, A, i dr.
Izdano: (2008)

FOXP1 abnormalities in lymphoma: Translocation breakpoint mapping reveals insights into deregulated transcriptional control
od: Goatly, A, i dr.
Izdano: (2008)

Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma
od: Giovanna Roncador, i dr.
Izdano: (2007-08-01)

Aberrant expression of the neuronal transcription factor FOXP2 in neoplastic plasma cells.
od: Campbell, A, i dr.
Izdano: (2010)

Therapeutic targeting of FOXP3-positive regulatory T cells using a FOXP3 peptide vaccine WO2008081581.
od: Banham, A, i dr.
Izdano: (2009)

Aberrant expression of the neuronal transcription factor FOXP2 in neoplastic plasma cells: Research paper
od: Campbell, A, i dr.
Izdano: (2010)

MALT1, BCL10 and FOXP1 in salivary gland mucosa-associated lymphoid tissue lymphomas.
od: Borovecki, A, i dr.
Izdano: (2007)

Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
od: Boultwood, J
Izdano: (2001)

Deregulated over expression of FOXP1 protein in diffuse large B-cell lymphoma does not occur as a result of gene rearrangement.
od: Barrans, S, i dr.
Izdano: (2007)

Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma.
od: Banham, A, i dr.
Izdano: (2005)

Adult T-cell leukaemia/lymphoma in an adolescent patient: Expect the unexpected
od: Ibtisam Abdullah, i dr.
Izdano: (2020-05-01)

FOXP3+ regulatory T cells as biomarkers in human malignancies.
od: Bignone, P, i dr.
Izdano: (2008)

FOXP3 expression in blood, synovial fluid and synovial tissue during inflammatory arthritis and intra-articular corticosteroid treatment.
od: Raghavan, S, i dr.
Izdano: (2009)

Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia.
od: Guinn, B, i dr.
Izdano: (2005)

Strong expression of FOXP1 predicts for poor prognosis within the non-germinal centre subgroup of diffuse large B cell lymphoma
od: Barrans, S, i dr.
Izdano: (2005)

t(3;14)(p14;q32) results in aberrant expression of FOXP1 in a case of diffuse large B-cell lymphoma.
od: Fenton, J, i dr.
Izdano: (2006)

Monoclonal antibodies raised to the human FOXP3 protein can be used effectively for detecting Foxp3(+) T cells in other mammalian species.
od: Banham, A, i dr.
Izdano: (2009)

The epidemiology of leukaemias and lymphomas: a review.
od: Kinlen, L
Izdano: (1977)

Therapeutic Modulation of Autophagy in Leukaemia and Lymphoma
od: Mojgan Djavaheri-Mergny, i dr.
Izdano: (2019-01-01)

CRISPR/Cas9-mediated Foxp1 silencing restores immune surveillance in an immunocompetent A20 lymphoma model
od: Felce, SL, i dr.
Izdano: (2020)

Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells.
od: Banham, A
Izdano: (2006)

Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.
od: Nyman, H, i dr.
Izdano: (2009)